Oncology: Immunotherapy
Immunotherapy
Classification
- Checkpoint Inhibitors
- Monoclonal Antibodies
- Cytokines
- Adoptive Cell Therapy
- Cancer Vaccines
Checkpoint Inhibitors
- Ipilimumab (Yervoy)- Mechanism: CTLA-4 Inhibitor (Stimulates at Immune Checkpoint)
- Use: Melanoma & RCC
 
- Pembrolizumab (Keytruda)- Mechanism: PD-1 Inhibitor
- Use: Melanoma, NSCLC, H&N SCC
 
- Nivolumab (Opdivo)- Mechanism: PD-1 Inhibitor
- Use: Melanoma, NSCLC, RCC
 
- Atezolizumab (Tecentriq)- Mechanism: PD-L1 Inhibitor
- Use: Lung Cancers, Liver Cancers & Breast Cancers
 
- Avelumab (Bavencio)- Mechanism: PD-L1 Inhibitor
- Use: Merkel Cell Carcinoma & Urothelial Cancers
 
- Durvalumab (Imfinzi)- Mechanism: PD-L1 Inhibitor
- Use: NSCLC
 
Monoclonal Antibodies (MAB)
- Bevacizumab (Avastin)- Mechanism: Anti-VEGF
- Use: Metastatic Colorectal CA- Can Affect the Liver & Should Limit Dose Prior to Metastasectomy
- Can Increase Risk of Leak
 
 
- Cetuximab (Erbitux)- Mechanism: Binds EGFR
- Use: Metastatic Colorectal CA (K-RAS Wild Type) & H&N Cancers
 
- Trastuzumab (Herceptin)- Mechanism: Binds HER2
- Use: Breast & Stomach Cancer
 
- Rituximab (Mabthera)- Mechanism: Binds CD-20
- Use: CLL & Non-Hodgkin Lymphoma
 
Cytokines
- Aldesleukin (IL-2/Proleukin)- Use: RCC
 
- Interferon (Intron A)- Rarely Used in Modern Practice
- Use: RCC & Leukemia
 
Adoptive Cell Therapy (Cellular Immunotherapy)
- Tumor-Infiltrating Lymphocyte (TIL) Therapy – Harvests Naturally Occurring T Cells Within the Tumor, Actives/Expands & Then Reinfuses Them
- Engineered T Cell Receptor (TCR) Therapy – Harvests Patient T Cells & Adds New T Cell Receptors to Target Specific Cancer Antigens
- Chimeric Antigen Receptor (CAR) T Cell Therapy – Equips T Cells with Synthetic Receptors
- Natural Killer (NK) Cell Therapy
Cancer Vaccines
- Prophylactic Vaccines:- Human Papillomavirus (HPV) Vaccine- Prevents Cervical Cancer & Some Anal/Throat Cancers
 
- Hepatitis B Virus (HBV) Vaccine- Prevents HBV & Associated HCC
 
 
- Human Papillomavirus (HPV) Vaccine
- Therapeutic Vaccines:- Bacillus Calmette-Guerin (BCG) Vaccine- Originally Developed for TB
- Now Used for Bladder Cancer Treatment
 
- Sipuleucel-T- Treats Advanced Prostate Cancer
 
- Talimogene Laherparepvec- Treats Melanoma
 
 
- Bacillus Calmette-Guerin (BCG) Vaccine